Westphal, F; Girreser, U; Waldmüller, D. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs Drug Test. Anal., 1 Sep 2016, 8 (9), 910-919. 2.2 MB. https://doi.org/10.1002/dta.1889 #4 MS,NMR,IR
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Liu, C; Jia, W; Qian, Z; Li, T; Hua, Z. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe: Identification of five substituted phenethylamine derivatives Drug Test. Anal., 1 Feb 2017, 9 (2), 199-207. 773 kB. https://doi.org/10.1002/dta.1955 #5 LC,MS,NMR
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #5-APB-NBOMe NMR
Richter, LHJ; Menges, J; Wagmann, L; Brandt, SD; Stratford, A; Westphal, F; Flockerzi, V; Meyer, MR. In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives: phase I and II metabolism, plasma protein binding, and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry Forensic Toxicol., 1 Jan 2020, 38 (1), 141-159. 1.4 MB. https://doi.org/10.1007/s11419-019-00498-7 #5-APB-NBOMe MS
NPA · Propylnorapomorphine